Local drug delivery has become an important treatment modality for the prevention of
thrombotic events following coronary angioplasty. In this study, we investigate the ability of …

Cell‐selective delivery using ligand‐decorated nanoparticles is a promising modality for
treating cancer and vascular diseases. We are developing liposome nanoparticles surface …

Platelet adhesion, activation and fibrinogen-mediated aggregation are primary events in
vascular thrombosis and occlusion. An injectable delivery system that can carry …

The present study was aimed to study the effect of RGD peptide conjugation on the bio-
distribution behaviour of long circulatory liposomes in the thrombosed rat model. Further …

Thrombosis, a critical event in blood vessels, not only is associated with myocardial
infarction and stroke, but also accounts for considerable morbidity and mortality …

Activated platelets play multiple roles in vascular diseases. Hence, a delivery vehicle that
can specifically target activated platelets and stay retained under a hemodynamic …

Summary Background: The dodecapeptide HHLGGAKQAGDV (H12), corresponding to the
fibrinogen γ‐chain carboxy‐terminal sequence (γ400‐411), is a specific binding site of the …

Cardiovascular disease processes such as atherosclerosis, restenosis, and inflammation
are typically localized to discrete regions of the vasculature, affording great opportunity for …

In recent times, search for potent and highly selective thrombolytic agents with minimal side
effects has become a major area of research. The aim of the present study was to develop …

Cyclic RGD peptide anchored sterically stabilized liposomes (RGD-SL) were investigated for
selective and preferential presentation of carrier contents at angiogenic endothelial cells …